Location History:
- Farmingdale, NY (US) (2009)
- Babylon, NY (US) (2013)
Company Filing History:
Years Active: 2009-2013
Title: Innovations in Cancer Treatment: The Contributions of Qun-Sheng Ji
Introduction: Qun-Sheng Ji is an accomplished inventor based in Babylon, NY, with a remarkable focus on advancing cancer therapies. He holds two patents aimed at improving treatments for tumors and related conditions, showcasing his dedication to innovative medical solutions.
Latest Patents: Ji's latest patents include groundbreaking methods and compositions for treating tumors or tumor metastases. His first patent details a combination cancer therapy that involves administering a therapeutically effective amount of an anti-cancer agent alongside an IGF1R inhibitor compound. This method can be implemented simultaneously or sequentially with additional cancer treatments such as chemotherapy or radiation therapy. His second patent focuses on substituted thienol[2,3-d]pyrimidines as kinase inhibitors. These compounds serve as IGF-1R enzyme inhibitors and hold promise for treating hyperproliferative diseases, including various cancers, inflammation, and immune system disorders.
Career Highlights: Qun-Sheng Ji has made significant strides in the pharmaceutical field while working at Osi Pharmaceuticals, Inc. His innovative contributions reflect a deep commitment to addressing complex health challenges, particularly in cancer treatment. His work exemplifies the intersection of science and patient care through targeted therapies.
Collaborations: Throughout his career, Qun-Sheng Ji has collaborated with esteemed colleagues, including Mark Joseph Mulvihill and Arno G Steinig. Their joint efforts showcase the importance of teamwork in driving forward-thinking solutions in the healthcare and pharmaceutical industries.
Conclusion: Qun-Sheng Ji represents the spirit of innovation within the realm of cancer therapy. His patents not only highlight his expertise as an inventor but also signify hope for many patients facing challenging health conditions. As research in this field continues to evolve, Ji’s contributions will undoubtedly pave the way for future advancements in cancer treatment.